VG Life Sciences Inc. (VGLS)

[Couch]

I'm actually getting a little excited about the support VG MDT compounds could lend to existing therapies. Getting more tumor control from a successful drug is a value proposition for VG. A new TKI can run $10-$15k per month for treatment.

I like the way you are thinking Umiak! Management is thinking the same :)

Both will be pursued equally but different sources of potential funding. MDT is most likely a collaboration situation, since it works with chemotherapy and off-course grant money. TPT technology will most likely be equity and grant funding.